Joel Reinoehl is a Cardiology physician affiliated with Bronson Methodist Hospital. OpenAlex indexes 11 publications with 271 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
601 John St
Ste 100
Kalamazoo, MI 490075341
Telephone
269-373-1592Provider last certified this registry record 23 Aug 2022.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20255 payments
- Actelion Pharmaceuticals US, Inc.Program year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
64.9%Beta blocker25.7%Metoprolol Succinate51%Sotalol19%Metoprolol Tartrate11%Nebivolol Hcl6%Carvedilol6%Atenolol4%Bisoprolol Fumarate3%Part D<11 patientsAntiarrhythmic15.3%Flecainide Acetate50%Amiodarone Hcl20%Dofetilide20%Mexiletine Hcl4%Propafenone Hcl Er4%Propafenone Hcl2%Part D<11 patients+ 11 more classes in this area
Blood & clotting
30%Factor Xa inhibitor25.3%Eliquis69%Xarelto31%Part D≥191 patientsVitamin K antagonist3.9%Warfarin Sodium84%Jantoven16%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
3.6%Potassium supplement3%Potassium Chloride100%Part D≥37 patientsH2 blocker0.7%Famotidine100%Part D≥25 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”